- Report
- August 2025
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
- Report
- March 2025
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
€4318EUR$4,850USD£3,773GBP
- Report
- February 2025
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
€4318EUR$4,850USD£3,773GBP
- Report
- February 2025
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
€4318EUR$4,850USD£3,773GBP
- Report
- February 2025
- 150 Pages
Global
From €3427EUR$3,850USD£2,995GBP
€4318EUR$4,850USD£3,773GBP
- Report
- June 2025
- 222 Pages
Global
From €3961EUR$4,450USD£3,461GBP
- Report
- July 2025
- 350 Pages
Global
From €4406EUR$4,949USD£3,850GBP
- Report
- August 2025
- 150 Pages
Global
From €2913EUR$3,273USD£2,545GBP
€3427EUR$3,850USD£2,995GBP
- Report
- August 2025
- 150 Pages
Global
From €2989EUR$3,358USD£2,612GBP
€3516EUR$3,950USD£3,072GBP
- Report
- June 2025
- 120 Pages
United States
From €5297EUR$5,950USD£4,628GBP
- Report
- August 2025
- 150 Pages
Middle East
From €4407EUR$4,950USD£3,850GBP
- Report
- August 2025
- 100 Pages
United States
From €3516EUR$3,950USD£3,072GBP
- Report
- July 2025
- 120 Pages
United States
From €5297EUR$5,950USD£4,628GBP
- Report
- September 2025
- 85 Pages
United States
From €3116EUR$3,500USD£2,722GBP
- Report
- July 2020
- 269 Pages
Global
From €3113EUR$3,497USD£2,720GBP
- Report
- August 2024
- 381 Pages
Global
From €4272EUR$4,799USD£3,733GBP
- Report
- February 2024
- 202 Pages
Global
From €4451EUR$5,000USD£3,889GBP
- Report
- October 2022
- 194 Pages
Global
From €4451EUR$5,000USD£3,889GBP
- Report
- January 2024
- 213 Pages
Global
From €4139EUR$4,650USD£3,617GBP
- Report
- September 2022
- 110 Pages
Global
From €4896EUR$5,500USD£4,278GBP

DNA vaccines are a type of genomics-based vaccine that uses genetic material from a virus or bacteria to stimulate an immune response. They are created by introducing a gene that codes for a specific antigen into a plasmid, which is then inserted into a host cell. The host cell then produces the antigen, which is then used to stimulate an immune response. DNA vaccines are considered to be safer than traditional vaccines, as they do not contain any live virus or bacteria. Additionally, they can be produced more quickly and cheaply than traditional vaccines.
DNA vaccines have been used to treat a variety of diseases, including influenza, malaria, and HIV. They have also been used to develop vaccines for cancer and other diseases. Recently, DNA vaccines have been used to develop vaccines for the prevention of infectious diseases, such as Zika virus and Ebola.
Companies in the DNA Vaccines market include Moderna, Inovio Pharmaceuticals, Novavax, and Transgene. Show Less Read more